Vallieri N, Datsi A
Cancers (Basel). 2025; 17(5).
PMID: 40075663
PMC: 11899300.
DOI: 10.3390/cancers17050817.
Wang T, Wang X, Ren W, Sun Z, Zhang Y, Wu N
Genes Dis. 2025; 12(3):101332.
PMID: 39935606
PMC: 11810708.
DOI: 10.1016/j.gendis.2024.101332.
Wu H, Liu Q, Wang F, Gao W, Zhou F, Zhao H
Onco Targets Ther. 2025; 18():87-106.
PMID: 39845286
PMC: 11752833.
DOI: 10.2147/OTT.S486411.
Garofalo S, DAlessandro G, Limatola C
Adv Neurobiol. 2024; 37:513-527.
PMID: 39207710
DOI: 10.1007/978-3-031-55529-9_28.
Thenuwara G, Javed B, Singh B, Tian F
Sensors (Basel). 2024; 24(9).
PMID: 38732975
PMC: 11086276.
DOI: 10.3390/s24092865.
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
Kocher D, Cao L, Guiho R, Langhammer M, Lai Y, Becker P
J Neurooncol. 2024; 168(2):317-332.
PMID: 38630384
PMC: 11147834.
DOI: 10.1007/s11060-024-04672-9.
Immune cells: potential carriers or agents for drug delivery to the central nervous system.
Zhang S, Li R, Chen Z, Wang X, Dumont A, Fan X
Mil Med Res. 2024; 11(1):19.
PMID: 38549161
PMC: 10979586.
DOI: 10.1186/s40779-024-00521-y.
The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy.
Chaudhri A, Bu X, Wang Y, Gomez M, Torchia J, Hua P
Front Immunol. 2023; 14:1237715.
PMID: 37771579
PMC: 10524267.
DOI: 10.3389/fimmu.2023.1237715.
Activin A-Mediated Polarization of Cancer-Associated Fibroblasts and Macrophages Confers Resistance to Checkpoint Immunotherapy in Skin Cancer.
Pich-Bavastro C, Yerly L, Di Domizio J, Tissot-Renaud S, Gilliet M, Kuonen F
Clin Cancer Res. 2023; 29(17):3498-3513.
PMID: 37327314
PMC: 10472111.
DOI: 10.1158/1078-0432.CCR-23-0219.
Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies.
Caverzan M, Beauge L, Oliveda P, Cesca Gonzalez B, Buhler E, Ibarra L
Brain Sci. 2023; 13(4).
PMID: 37190507
PMC: 10136702.
DOI: 10.3390/brainsci13040542.
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
Erices J, Bizama C, Niechi I, Uribe D, Rosales A, Fabres K
Int J Mol Sci. 2023; 24(8).
PMID: 37108208
PMC: 10139189.
DOI: 10.3390/ijms24087047.
Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment.
Dean P, Hooks S
Front Oncol. 2023; 12:1116014.
PMID: 36776369
PMC: 9909545.
DOI: 10.3389/fonc.2022.1116014.
Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities.
Wang G, Zhong K, Wang Z, Zhang Z, Tang X, Tong A
Front Immunol. 2022; 13:964898.
PMID: 35967394
PMC: 9363573.
DOI: 10.3389/fimmu.2022.964898.
Dialogue among Lymphocytes and Microglia in Glioblastoma Microenvironment.
Mormino A, Garofalo S
Cancers (Basel). 2022; 14(11).
PMID: 35681612
PMC: 9179556.
DOI: 10.3390/cancers14112632.
[Interference of P2X4 receptor expression in tumor-associated macrophages suppresses migration and invasion of glioma cells].
Yang X, Shen H, Li Q, Dai Z, Yang R, Huang G
Nan Fang Yi Ke Da Xue Xue Bao. 2022; 42(5):658-664.
PMID: 35673908
PMC: 9178632.
DOI: 10.12122/j.issn.1673-4254.2022.05.05.
Systematic Review on Tumor Microenvironment in Glial Neoplasm: From Understanding Pathogenesis to Future Therapeutic Perspectives.
Bianconi A, Aruta G, Rizzo F, Salvati L, Zeppa P, Garbossa D
Int J Mol Sci. 2022; 23(8).
PMID: 35456984
PMC: 9029619.
DOI: 10.3390/ijms23084166.
The Pivotal Immunoregulatory Functions of Microglia and Macrophages in Glioma Pathogenesis and Therapy.
Richard S
J Oncol. 2022; 2022:8903482.
PMID: 35419058
PMC: 9001141.
DOI: 10.1155/2022/8903482.
The Subventricular Zone in Glioblastoma: Genesis, Maintenance, and Modeling.
Beiriger J, Habib A, Jovanovich N, Kodavali C, Edwards L, Amankulor N
Front Oncol. 2022; 12:790976.
PMID: 35359410
PMC: 8960165.
DOI: 10.3389/fonc.2022.790976.
Patient-Oriented Perspective on Chemokine Receptor Expression and Function in Glioma.
Isci D, DUonnolo G, Wantz M, Rogister B, Lombard A, Chevigne A
Cancers (Basel). 2022; 14(1).
PMID: 35008294
PMC: 8749846.
DOI: 10.3390/cancers14010130.
NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas.
Pan C, Zhai Y, Li G, Jiang T, Zhang W
Front Oncol. 2021; 11:751183.
PMID: 34765554
PMC: 8576093.
DOI: 10.3389/fonc.2021.751183.